|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 489/08 | |
| A61K 9/00 | |||
| A61K 47/08 | |||
| A61P 25/36 |
| (11) | Number of the document | 3526223 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17787671.1 |
| Date of filing the European patent application | 2017-10-06 | |
| (97) | Date of publication of the European application | 2019-08-21 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/SK2017/000008 |
| Date | 2017-10-06 |
| (87) | Number | WO 2018/070943 |
| Date | 2018-04-19 |
| (30) | Number | Date | Country code |
| 50282016 | 2016-10-11 | SK |
| (72) |
KAVALA, Miroslav, SK
VAND K, Dusan, SK
PAL K, Miroslav, SK
GASPAR, Jįn, SK
HERCEK, Richard, SK
|
| (73) |
Saneca Pharmaceuticals a.s.,
Nitrianska 100, 920 27 Hlohovec,
SK
|
| (54) | METHOD FOR ISOLATION AND PURIFICATION OF NALTREXONE |
| METHOD FOR ISOLATION AND PURIFICATION OF NALTREXONE |